% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Bhardwaj:147388,
author = {M. Bhardwaj$^*$ and K. Weigl$^*$ and K. Tikk$^*$ and A.
Benner$^*$ and P. Schrotz-King$^*$ and H. Brenner$^*$},
title = {{M}ultiplex screening of 275 plasma protein biomarkers to
identify a signature for early detection of colorectal
cancer.},
journal = {Molecular oncology},
volume = {14},
number = {1},
issn = {1878-0261},
address = {Hoboken, NJ},
publisher = {John Wiley $\&$ Sons, Inc.},
reportid = {DKFZ-2019-02505},
pages = {8-21},
year = {2020},
note = {2020 Jan;14(1):8-21#EA:C120#LA:C070#},
abstract = {Blood-based protein biomarkers may be an attractive option
for early detection of colorectal cancer (CRC). Here, we
used a two-stage design to measure 275 protein markers by
proximity extension assay (PEA), first in plasma samples of
a discovery set consisting of 98 newly diagnosed CRC cases
and 100 age and gender matched controls free of neoplasm at
screening colonoscopy. An algorithm predicting the presence
of early or late stage CRC was derived by Lasso regression
with .632+ bootstrap method and the algorithms were then
validated using PEA again in an independent validation set
consisting of participants of screening colonoscopy with and
without CRC (n= 56 and 102, respectively). Three different
signatures for all, early, and late stages CRC consisting of
9, 12, and 11 protein markers were obtained in the discovery
set with areas under the curves (AUCs) after .632+ bootstrap
adjustment of 0.92, 0.91 and 0.96, respectively. External
validation among participants of screening colonoscopy
yielded AUCs of 0.76 $(95\%CI,$ 0.67-0.84), 0.75 $(95\%CI,$
0.62-0.87) and 0.80 $(95\%CI,$ 0.68-0.89) for all, early,
and late stage CRC, respectively. Although the identified
protein markers are not competitive with the best available
stool tests, these proteins may contribute to the
development of powerful blood-based tests for CRC early
detection in the future.},
cin = {C120 / C070 / HD01 / C060},
ddc = {610},
cid = {I:(DE-He78)C120-20160331 / I:(DE-He78)C070-20160331 /
I:(DE-He78)HD01-20160331 / I:(DE-He78)C060-20160331},
pnm = {313 - Cancer risk factors and prevention (POF3-313)},
pid = {G:(DE-HGF)POF3-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:31652396},
doi = {10.1002/1878-0261.12591},
url = {https://inrepo02.dkfz.de/record/147388},
}